Image Guided Radiotherapy Market Size & Growth Forecast 2027–2036, By Segments (Product Type, End-use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Image Guided Radiotherapy Market size was worth USD 2.28 Billion in 2026 and is expected to grow at 7.74% CAGR between 2027 and 2036, reaching USD 4.81 Billion by 2036. The industry revenue for 2027 is assessed at USD 2.43 Billion.
Get more details on this report
Request Free Sample ReportImage Guided Radiotherapy Market Intelligence Snapshot
Regional Market Dynamics
- North America held 44.73% of the market in 2026, supported by advanced healthcare infrastructure, specialized oncology facilities, precision technology adoption, and established reimbursement frameworks.
- Asia Pacific is growing rapidly through hospital modernization, expanding oncology services, rising cancer treatment needs, government healthcare initiatives, and greater adoption of precision-based technologies.
Segment Momentum
- Radiotherapy/LINAC devices held a 56.82% market share in 2026 because they are essential for precise radiation delivery, improving treatment accuracy, dose optimization, and clinical outcomes across multiple cancer indications.
- Radiotherapy centers are expanding rapidly as demand grows for specialized oncology facilities that offer streamlined workflows, greater treatment capacity, and improved patient access to dedicated radiation therapy services.
Market Expansion Drivers
- Increasing cancer incidence driving adoption of precision image guided radiotherapy systems
- Rising preference for personalized cancer treatment planning enhancing radiotherapy precision demand
- Shift toward non-invasive cancer treatment accelerating adoption of advanced radiotherapy technologies
Leading Market Participants
- Prominent companies in the image guided radiotherapy market include Siemens Healthineers AG (Germany), Elekta AB (Sweden), Varian Medical Systems, Inc. (United States), GE HealthCare Technologies Inc. (United States), Philips N.V. (Netherlands), Accuray Incorporated (United States), C-RAD AB (Sweden), Hitachi, Ltd. (Japan), Brainlab AG (Germany)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2.28 Billion
- 2027 Estimated Market Size: USD 2.43 Billion
- Projected Market Size: USD 4.81 Billion by 2036
- Growth Forecast: 7.74% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Radiotherapy/LINAC (Linear Accelerators) Devices (Product Type) | Hospitals (End-use) | Breast Cancer (Application)
- Emerging Opportunity Segment: Imaging Devices (Product Type) | Radiotherapy Centers (End-use) | Lung Cancer (Application)
Market Growth Drivers and Industry Trends
Increasing cancer incidence driving adoption of precision image guided radiotherapy systems
The rising global burden of cancer is creating greater demand for advanced treatment technologies, and the image guided radiotherapy market is benefiting from the need to deliver highly accurate radiation therapy across a growing patient population. Image-guided systems enable clinicians to verify tumor position before and during treatment, improving targeting precision while helping minimize radiation exposure to surrounding healthy tissues. Healthcare providers are increasingly integrating these capabilities into oncology workflows to manage complex cases requiring consistent treatment accuracy.
Rising preference for personalized cancer treatment planning enhancing radiotherapy precision demand
Personalized oncology is reshaping radiation therapy practices, with the image guided radiotherapy market gaining momentum as clinicians tailor treatment plans according to individual tumor characteristics and patient-specific anatomical changes. Advanced imaging incorporated into radiotherapy workflows supports adaptive treatment strategies by allowing continuous assessment of target location and therapy response throughout the treatment course. This individualized approach enables more precise dose delivery while accommodating variations that may occur during repeated treatment sessions.
Shift toward non-invasive cancer treatment accelerating adoption of advanced radiotherapy technologies
Healthcare providers and patients are increasingly favoring non-invasive treatment approaches, which will boost the image guided radiotherapy market demand by expanding the use of technologies capable of treating tumors without surgical intervention. Image-guided radiotherapy offers precise radiation delivery while reducing the need for invasive procedures in appropriately selected cases, making it an important option within multidisciplinary cancer care. Clinical emphasis on preserving healthy tissue, minimizing treatment-related complications, and improving patient experience is encouraging broader implementation of advanced radiotherapy platforms.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing cancer incidence driving adoption of precision image guided radiotherapy systems | 2% | High | North America, Europe | High | Near Term |
| Rising preference for personalized cancer treatment planning enhancing radiotherapy precision demand | 1.8% | High | Asia Pacific, North America | High | Mid Term |
| Shift toward non-invasive cancer treatment accelerating adoption of advanced radiotherapy technologies | 1.6% | High | Europe, Asia Pacific | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the image guided radiotherapy market, North America held the largest share of 44.73% in 2026, supported by advanced healthcare infrastructure, strong adoption of precision radiation technologies, and continued investment in modern cancer treatment capabilities. The region benefits from a high concentration of specialized oncology facilities and increasing clinical emphasis on accurate tumor targeting, treatment verification, and minimizing radiation exposure to surrounding healthy tissue. Growing demand for technologically advanced radiotherapy solutions, combined with established reimbursement frameworks and ongoing healthcare modernization, continues to reinforce North America's market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is projected to emerge as the fastest-growing region, driven by expanding healthcare infrastructure, rising cancer treatment needs, and increasing adoption of advanced medical technologies across developing healthcare systems. Improvements in access to specialized oncology services, greater investment in hospital modernization, and growing awareness of precision-based treatment approaches are supporting demand for image-guided radiotherapy solutions. In addition, government initiatives aimed at strengthening healthcare capacity and the expansion of private healthcare facilities are creating favorable conditions for broader deployment of advanced radiotherapy technologies across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Precision oncology adoptionIn the U.S., image guided radiotherapy is widely integrated into advanced oncology centers where precision targeting and adaptive treatment planning are prioritized. Hospitals focus on upgrading linear accelerators with real-time imaging capabilities to improve tumor localization and treatment accuracy.
Germany 🇩🇪
High-end treatment integrationIn Germany, adoption is concentrated in specialized cancer treatment centers emphasizing high-precision radiotherapy workflows and integration of advanced imaging modalities. Providers prioritize system interoperability, treatment accuracy, and compliance with stringent clinical quality standards.
Japan 🇯🇵
Technology-driven oncology careIn Japan, image guided radiotherapy is supported by strong investments in technologically advanced cancer care systems, with emphasis on compact, highly automated treatment platforms. Hospitals focus on improving accuracy while managing high patient throughput in urban medical centers.
South Korea 🇰🇷
Rapid oncology modernizationIn South Korea, oncology centers are rapidly upgrading radiotherapy infrastructure with image guidance systems to enhance treatment precision and efficiency. The market prioritizes integration of advanced imaging with workflow automation in high-volume hospitals.
France 🇫🇷
Centralized cancer treatmentIn France, image guided radiotherapy adoption is concentrated in centralized oncology networks where standardized treatment protocols and imaging-assisted targeting improve consistency. Investment focuses on upgrading public hospital radiotherapy units with advanced imaging integration.
Italy 🇮🇹
Regional oncology upgradesIn Italy, demand is driven by modernization of regional cancer centers where image guided radiotherapy systems are being introduced to improve treatment precision. Healthcare providers emphasize phased equipment upgrades aligned with public healthcare budgeting cycles.
Segment Leadership and Growth Trends
Image Guided Radiotherapy Market Share (%), Product Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Type Segment Analysis: Radiotherapy/LINAC (Linear Accelerators) Devices (Largest Segment) vs Imaging Devices (Fastest-Growing Segment)
The radiotherapy/LINAC (linear accelerators) devices segment led the image guided radiotherapy market with a 56.82% share in 2026. Its dominant position is attributed to the central role these systems play in delivering precise radiation treatment across a wide range of cancer indications. Healthcare providers continue to invest in advanced linear accelerator technologies to improve treatment accuracy, optimize dose delivery, and enhance clinical outcomes, supporting the segment’s sustained market leadership.
The imaging devices segment is projected to experience the fastest growth owing to the increasing importance of real-time visualization and treatment guidance in modern radiation oncology. Advanced imaging technologies enable clinicians to monitor tumor positioning, adapt treatment plans, and minimize radiation exposure to surrounding healthy tissues. As the industry places greater emphasis on precision medicine and personalized cancer care, demand for sophisticated imaging capabilities is expected to accelerate.
End-use Segment Analysis: Hospitals (Largest Segment) vs Radiotherapy Centers (Fastest-Growing Segment)
Hospitals accounted for the largest share of the image guided radiotherapy market at 50.03% in 2026. Their leadership stems from the availability of comprehensive oncology services, multidisciplinary treatment teams, and the financial capacity to invest in advanced radiotherapy infrastructure. Hospitals often serve as primary treatment hubs for cancer patients, enabling them to maintain a strong position in the adoption of image guided radiotherapy technologies.
Radiotherapy centers represent the fastest-growing end-use segment due to the increasing specialization of cancer treatment services and rising demand for dedicated radiation therapy facilities. These centers are designed to focus exclusively on oncology care, allowing streamlined workflows, greater treatment capacity, and enhanced patient access. Continued expansion of specialized cancer care networks is expected to support the rapid growth of this segment.
Application Segment Analysis: Breast Cancer (Largest Segment) vs Lung Cancer (Fastest-Growing Segment)
Breast cancer emerged as the largest application segment in 2026, capturing 27.54% of the image guided radiotherapy market. The segment benefits from the widespread use of radiotherapy as a key component of breast cancer treatment, particularly following surgical interventions. Growing awareness, expanding screening programs, and the need for precise radiation delivery to protect surrounding healthy tissues have reinforced the adoption of image guided radiotherapy in breast cancer management.
The lung cancer segment is anticipated to register the fastest growth as the need for highly accurate radiation treatment becomes increasingly important in managing tumors affected by respiratory motion. Image guided radiotherapy provides enhanced targeting capabilities that help clinicians improve treatment precision while reducing exposure to nearby organs. Rising focus on advanced treatment approaches for complex thoracic cancers continues to support growth within this application area.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product Type | Radiotherapy/LINAC (Linear Accelerators) Devices, Imaging Devices | Radiotherapy/LINAC (Linear Accelerators) Devices | Imaging Devices |
| End-use | Hospitals, Radiotherapy Centers, Others | Hospitals | Radiotherapy Centers |
| Application | Breast Cancer, Lung Cancer, Brain Tumor, Prostate Cancer, Gastrointestinal Cancer, Gynecological Cancer, Others | Breast Cancer | Lung Cancer |
Competitive Landscape and Market Positioning
Key companies in the image guided radiotherapy market:
- Siemens Healthineers AG (Germany)
- Elekta AB (Sweden)
- Varian Medical Systems, Inc. (United States)
- GE HealthCare Technologies, Inc. (United States)
- Philips N.V. (Netherlands)
- Accuray Incorporated (United States)
- C-RAD AB (Sweden)
- Hitachi Ltd. (Japan)
- Brainlab AG (Germany)
Advancements in precision treatment approaches are intensifying competitive pressure within the Image Guided Radiotherapy Market. Participants are differentiating through improved imaging accuracy, treatment workflow integration, and solutions that support more personalized oncology procedures. The market is moving toward technology-driven competition, where providers with stronger capabilities in system interoperability and clinical efficiency are better positioned to address the growing demand for advanced radiation therapy solutions.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Siemens Healthineers AG (Germany) | |||||||
| Elekta AB (Sweden) | |||||||
| Varian Medical Systems Inc. (United States) | |||||||
| GE HealthCare Technologies Inc. (United States) | |||||||
| Philips N.V. (Netherlands) | |||||||
| Accuray Incorporated (United States) | |||||||
| C-RAD AB (Sweden) | |||||||
| Hitachi Ltd. (Japan) | |||||||
| Brainlab AG (Germany) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| St. Luke’s Medical Center – Quezon City | Jul-26 | St. Luke’s Medical Center – Quezon City launched the first TrueBeam Edge radiotherapy system in the Philippines. The deployment introduces advanced image-guided capabilities to the country's healthcare infrastructure, strengthening the institution's position in high-precision oncology delivery. |
| Dr. L H Hiranandani Hospital | Jun-26 | Dr. L H Hiranandani Hospital expanded its oncology services through the commissioning of the Halcyon radiation therapy system. This technological integration enhances the hospital's delivery footprint by providing advanced radiotherapy capabilities to scale up local cancer care infrastructure. |
| GenesisCare | Jun-26 | GenesisCare upgraded its Milton Keynes cancer centre with new diagnostic imaging and radiotherapy equipment. The infrastructure expansion forms part of a broader capital investment strategy across its UK cancer care network to enhance clinical treatment capacity. |
| Hamad Medical Corporation | Oct-25 | Hamad Medical Corporation achieved formal accreditation as an International Atomic Energy Agency Collaborating Centre in radiation medicine. The designation formalizes its position as a regional hub for educational innovation and clinical advancement in radiotherapy and nuclear medicine. |
| Varian (A Siemens Healthineers Company) | Apr-25 | Varian prioritized public-private collaborations to scale the adoption of adaptive radiotherapy technologies in India. The strategic initiative targets broader infrastructure access, driving the commercial penetration of modern image-guided cancer treatment solutions across emerging healthcare networks. |
| Sahyadri Hospitals | Aug-24 | Sahyadri Hospitals commissioned Asia's first Radixact X9 radiotherapy system equipped with VitalHold Technology. The installation introduces AI-enabled intra-fraction imaging capabilities, significantly improving tumor targeting precision and setting a new benchmark for competitive clinical operations in region. |
| Hospital de Clínicas da Unicamp | Jun-24 | Hospital de Clínicas da Unicamp deployed a new high-precision radiotherapy system designed to double the facility's existing cancer treatment capacity. The technological upgrade optimizes patient throughput by enabling faster delivery protocols while minimizing operational risk and procedural side effects. |
| Hitachi, Ltd. | Oct-23 | Hitachi completed the delivery and initial patient treatment of its first proton therapy system in Southeast Asia at the National Cancer Centre Singapore. This deployment expands the company's regional footprint in advanced radiation oncology and establishes its high-precision therapeutic technology within the market. |
| Elekta | Oct-20 | Elekta launched the Elekta Harmony linear accelerator, expanding its core portfolio of cancer treatment systems. The commercial roll-out of this linac technology enhanced the company's competitive product offering and supported market-wide diversification in linear accelerator infrastructure. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Image Guided Radiotherapy Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Imaging Modality | Cone-Beam Computed Tomography (CBCT), Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Other Imaging Modalities |
| Treatment Technique | Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Stereotactic Radiotherapy, Volumetric Modulated Arc Therapy (VMAT), 3D Conformal Radiation Therapy, Other Techniques |
| Workflow Integration | Standalone Systems, Integrated Imaging-Radiotherapy Systems, Fully Automated Image-Guided Workflows |
Image Guided Radiotherapy Market — report.custom
| Custom Chapter | Custom Details |
|---|---|
| Oncology Center Investment Prioritization |
|
| Radiotherapy Equipment Replacement Cycle Analysis |
|
| Hospital Procurement Decision Framework |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of image guided radiotherapy?
How is the image guided radiotherapy industry size expected to evolve during the forecast period?
How is increasing cancer incidence accelerating adoption of image guided radiotherapy systems?
Why is personalized treatment planning becoming a key driver in the image guided radiotherapy market?
Why do radiotherapy/LINAC devices lead the image guided radiotherapy market?
Why are radiotherapy centers the fastest-growing end users in the image guided radiotherapy market?
How does North America maintain its leadership in image guided radiotherapy?
What is driving rapid growth of image guided radiotherapy in Asia Pacific?
Which companies dominate the image guided radiotherapy landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization